Cebranopadol
- Generic Name
- Cebranopadol
- Drug Type
- Small Molecule
- Chemical Formula
- C24H27FN2O
- CAS Number
- 863513-91-1
- Unique Ingredient Identifier
- 7GDW9S3GN3
- Background
Cebranopadol has been used in trials studying the treatment of Pain, Neoplasms, and Chronic Pain.
Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain
Phase 2
Completed
- Conditions
- Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
- Interventions
- First Posted Date
- 2012-10-18
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Tris Pharma, Inc.
- Target Recruit Count
- 619
- Registration Number
- NCT01709214
- Locations
- 🇺🇸
Site 011, Bradenton, Florida, United States
🇺🇸Site 061, Fresno, California, United States
🇺🇸Site 043, Tustin, California, United States
Assessment of GRT6005 in Painful Osteoarthritis of the Knee
Phase 2
Completed
- Conditions
- Osteoarthritis of the Knee
- Interventions
- Drug: Matching Placebo
- First Posted Date
- 2011-05-23
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Tris Pharma, Inc.
- Target Recruit Count
- 207
- Registration Number
- NCT01357837
- Locations
- 🇦🇹
Site 3604, Linz, Austria
🇦🇹Site 3605, Senftenberg, Austria
🇦🇹Site 3603, Wien, Austria
Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy
- First Posted Date
- 2011-05-04
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Tris Pharma, Inc.
- Target Recruit Count
- 189
- Registration Number
- NCT01347671
- Locations
- 🇩🇪
Site 4112, Aschaffenburg, Germany
🇩🇪Site 4109, Bad Oeynhausen, Germany
🇩🇪Site 4101, Berlin, Germany
Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic
Phase 2
Completed
- Conditions
- Diabetic Polyneuropathy
- Interventions
- First Posted Date
- 2009-04-08
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Tris Pharma, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT00878293
- Locations
- 🇩🇪
Investigator 3, Bad Oeynhausen, Germany
🇩🇪Investigator 1, Mainz, Germany
🇩🇪Investigator 2, Münster, Germany
Bunionectomy Trial With GRT6005
- First Posted Date
- 2009-03-31
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Tris Pharma, Inc.
- Target Recruit Count
- 258
- Registration Number
- NCT00872885
- Locations
- 🇺🇸
Premier Research Group Ltd, Austin, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath